RNCS Free Assessment
Service 5

Saudi Arabia Registration

The Saudi Food and Drug Authority (SFDA) is the primary regulatory body governing the marketing, import, and distribution of medical devices and in vitro diagnostics (IVDs) in the Kingdom of Saudi Arabia (KSA). As a member of the International Medical Device Regulators Forum (IMDRF), Saudi Arabia's medical device regulations are similar to those in the EU under the MDR, though the SFDA maintains its own distinct classification system, submission portal, and documentation requirements.

Get Your Free Regulatory AssessmentAdditional topics on SFDA registrationLast reviewed: November 2026

Before a medical device can be legally marketed in the KSA, manufacturers must obtain a Medical Device Marketing Authorization (MDMA) — the official approval confirming that a device meets SFDA's regulatory, safety, and performance requirements based on a full technical file review. Devices are classified into four risk-based classes, Class A, B, C, and D, based on 22 classification rules for medical devices and seven rules for IVDs. All submissions are made electronically through SFDA's Unified Electronic System (GHAD).

Saudi Arabia Pathway at a Glance

StepWhat happensIndicative time
1. Appoint Authorized RepresentativeLicensed AR registered in the Medical Devices National Registry (MDNR)1–4 weeks
2. Classify deviceSFDA Class A–D using the MDS-G008 rules1 week
3. Prepare technical fileTechnical File Assessment (TFA) dossier, labeling (Arabic for lay users), UDI data4–8 weeks
4. Submit via GHADApplication and fee payment1–2 weeks
5. SFDA reviewOfficial review: 35 working days, excluding time taken to answer queries2–5 months in practice
6. MDMA issuedValid up to 3 years; renew before expiry—

Need for Local Authorized Representative

Foreign manufacturers without a legal entity in Saudi Arabia are required to appoint a Local Authorized Representative (LAR) to act on their behalf. The Authorized Representative must obtain an Authorized Representative License, renewable annually, to legally represent the manufacturer in the KSA, and is responsible for submitting all application documents to the SFDA for device registration.

The LAR's role extends well beyond filing your application. Their name, address, and contact information appear on the device's technical documentation, labeling, packaging, and instructions for use, and they are responsible for maintaining post-market compliance and vigilance including reporting device modifications and adverse events to the SFDA, as well as submitting renewal applications to keep the registration active. Each LAR must be duly licensed with the SFDA and register through the Medical Devices National Registry portal to obtain a national registry number.

Because the AR is your legal presence in the KSA, check three things before you sign:

  • the AR's licence is current;
  • it has handled devices like yours before;
  • it has a clear way of passing SFDA's queries to you, and quickly.

If you change LARs later, a registration can be transferred to the new one through SFDA's systems. Plan the handover so market access never lapses.

Without a properly appointed and licensed LAR, a foreign manufacturer cannot register or market a device in KSA. We help can connect you with a trusted, experienced LAR, where needed, to manage this role reliably.

Device Classification: Class A to D

The SFDA classifies medical devices into four risk-based categories — Class A, B, C, and D — with Class A representing the lowest risk and Class D the highest. Classification is determined using 22 defined rules for medical devices and seven rules for IVDs, based on factors such as duration of body contact, invasiveness, and intended use.

Class decides the route:

  • Class A (low risk): may qualify for the Medical Device Listing (MDL) route instead of full review.
  • Class B, C and D: full Medical Device Marketing Authorization (MDMA).
  • Class A with extra risk factors: devices supplied sterile, with a measuring function, or that are reusable surgical instruments follow the MDMA route too.

Before settling on a class, compare how your device is classified in your reference markets (US, EU, Canada, Australia, Japan). SFDA's rules don't map one for one onto theirs, so the same device can land in a different class. In case of any confusion, resolve that before you build the file.

Accurate classification at the outset ensures the right documentation is prepared from day one, avoiding delays later in the process.

Read more about SFDA Device Classification (MDS-G008) →

Guidance on Medical Devices Classification (MDS – G008) (SFDA) →

MDMA Registration (Technical File Assessment)

Under MDS-REQ 1, a device can be made available in the Kingdom of Saudi Arabia only if it is registered and holds an MDMA. Medical Device Marketing Authorization (MDMA) is the official SFDA approval required based on a comprehensive review of the technical file. Since January 2022 the applicable route has been MDMA-2 where SFDA carries out its own Technical File Assessment (TFA) and conformity evaluation, whatever approvals you already hold abroad.

Regulation Update: MDMA-1 — Previously allowed devices already approved in GHTF reference markets (EU, US, Canada, Australia, Japan) to leverage those approvals for Saudi registration. This pathway was discontinued at the end of 2021. If the licence was issued under GHTF, this will have to be renewed under TFA.

So, does your CE or FDA paperwork still help? Yes, a lot. Most of what SFDA asks for already sits in a well-built CE or FDA file: the device description, risk management, verification and validation, clinical evidence and labeling. The work is reorganizing it to SFDA's structure and closing the gaps.

In practice, this stage covers:

  • compiling and organizing the technical file to SFDA's requirements;
  • preparing the supporting documents;
  • submitting through the GHAD electronic system and answering SFDA's queries.

Our goal is to help you build a submission that moves efficiently through SFDA review.

Read more about MDMA Registration and the Technical File Assessment →

Labelling & Documentation: Arabic and English Requirements

Language depends on who uses the device. Technical documentation is generally accepted in English. For professional-use devices, labeling and instructions for use (IFU) may also be in English. For devices used by lay users, including home-use devices, SFDA's essential principles call for information and any electronic user interface in both Arabic and English. Self-testing IVDs follow the same rule.

Two smaller points catch people out. Labels must not carry the SFDA logo, but they may show the Medical Device National Listing number. And the LAR's name and address must appear on the labeling, packaging and IFU.

We help with:

  • reviewing your labeling and IFU against SFDA's language requirements;
  • coordinating translation and localization where Arabic is needed;
  • keeping the technical file, labeling and marketing materials consistent with one another;
  • formatting documents to SFDA's submission standards.

Getting this right the first time saves a round of queries during review.

Post-Market Surveillance & Vigilance (NCMDR Reporting)

Once a device is on the market, manufacturers, Local Authorized Representative, importers, distributors, and healthcare providers share ongoing responsibility for monitoring device safety and performance. Adverse events and complaints are reported to the National Center for Medical Device Reporting (NCMDR). The manufacturer is also expected to conduct follow-up investigations and provide all relevant documentation and information SFDA asks for.

A few other duties are worth building into your procedures from day one:

  • A post-market surveillance plan and report that MDS-REQ 1 lists among the documents for authorization.
  • A distribution tracking system for manufacturers, LARs, importers and distributors to record who the device is supplied to.
  • Change notifications to be sent to SFDA electronically about any significant changes, within the 10-day window set by MDS-REQ 1.
  • Response time for documentation requested by SFDA. Even after MDMA is granted, SFDA can ask for your technical documentation at any time and expects it within 10 days. Procedure should be in place to address these requests.

We help set up surveillance and vigilance processes that match these requirements, support adverse event and complaint reporting, and coordinate the investigation and paperwork when an incident is reported. A process that is already running when something goes wrong makes a far better impression than one assembled in a hurry.

Keeping MDMA Valid: Renewal Support

An MDMA certificate is generally valid for three (3) years. MDS-REQ 1 requires it to be renewed before it expires, and a renewal request can be submitted up to 90 days before the expiry date. So, the practical window opens about three months before the deadline, and it's better to use it.

Renewal requires demonstrating ongoing compliance with SFDA requirements and may involve updates to technical documentation, labeling, or other supporting information reflecting any changes since initial authorization. If your licence was issued under the old GHTF route, the renewal will go through a full Technical File Assessment.

With renewal support built into our services, we help ensure your device registration remains continuously valid, to avoid any gaps in market authorization.

Why Work With Us

SFDA registration has several moving parts, and each one depends on the last. We handle them as one journey rather than a set of separate tasks.

  • One team from classification to renewal: The same people who classify your device prepare the file and plan the renewal, so nothing gets lost in a handover.
  • Built on SFDA's own documents: We work from the requirements themselves, such as MDS-REQ 1 and MDS-G008, not from second-hand summaries.
  • Your existing work, put to use: We adapt your CE or FDA documentation to SFDA's format instead of starting again.
  • Local representation arranged: Where you need a Local Authorized Representative, we connect you with an experienced, licensed one.
Ready to Get Started?

Whether you’re entering Saudi Arabia for the first time or renewing an existing registration, it helps to talk before you file. Tell us about your device, its intended use and where it is already approved. We’ll tell you how SFDA is likely to classify it, how much of your CE or FDA file you can reuse, and where the delays tend to come from. There’s no commitment at this stage.

Get in touch and we’ll map out your route to the Saudi market, step by step

Contact us today
Did you know?
  • Saudi Arabia is one of the largest medical device markets in the Middle East, making SFDA registration a key step for market access.
  • Foreign manufacturers typically need to appoint an authorized representative in Saudi Arabia to support regulatory interactions.
Saudi Arabia Registration – Frequently Asked Questions
Can I use my CE certificate or FDA clearance for SFDA approval?

Not as a shortcut. Since 2022, every device goes through a full SFDA Technical File Assessment. Your CE or FDA documentation is still extremely valuable, because most of the file can be reused and reformatted.

Can I change my Authorized Representative?

Yes. Registrations can be transferred to a new licensed AR through the SFDA systems. Plan the transfer carefully so there is no gap in market access.

Does labeling have to be in Arabic?

Labeling and IFUs for devices used by lay users (home use) must include Arabic. Professional-use devices may use English.

How long does registration take?

SFDA's official review target is 35 working days, not counting the time you spend answering queries. In practice, plan on two to five months for the review, plus the time to prepare the file.

How long is an MDMA valid, and when should I renew?

Generally, three years. You can submit a renewal request up to 90 days before the expiry date, and it must be renewed before the certificate expires.

View All FAQs →
Contact us today

Tell us about your device and target market. Our regulatory specialist, not a salesperson, will reply within one business day.

Get Your Free Regulatory Assessment